Scarica l'app Stockscreener
2.82
2.76%
-0.08
Pre-mercato:
2.85
0.03
+1.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.90
Aprire:
$3.03
Volume 24 ore:
2.40M
Relative Volume:
3.71
Capitalizzazione di mercato:
$150.12M
Reddito:
-
Utile/perdita netta:
$-52.35M
Rapporto P/E:
-2.0467
EPS:
-1.3778
Flusso di cassa netto:
$-40.68M
1 W Prestazione:
-30.20%
1M Prestazione:
-38.96%
6M Prestazione:
-5.05%
1 anno Prestazione:
-1.40%
Intervallo 1D:
$2.775
$3.05
Intervallo di 1 settimana:
$2.775
$4.16
Portata 52W:
$1.84
$6.025
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.82 | 154.38M | 0 | -52.35M | -40.68M | -1.3778 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
H.C. Wainwright reiterates Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada
Achieve Life Sciences (ACHV): HC Wainwright & Co. Reiterates Buy Rating | ACHV Stock News - GuruFocus
Earnings Call Summary | Achieve Life(ACHV.US) Q4 2025 Earnings Conference - 富途牛牛
Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by US manufacturing shift and AI-driven commercialization - MSN
Achieve Life Sciences stock falls as commercial launch pushed to 2027 - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus
Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Achieve Life Sciences Reports 2025 Financial Results, Advances Cytisinicline NDA for Smoking and Vaping Cessation, Announces U.S. Manufacturing Partnership with Adare Pharma Solutions 12 - Minichart
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences Q4 Earnings Call Highlights - MarketBeat
Achieve Life Sciences, Inc. 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights - Minichart
ACHV: Cytisinicline NDA accepted; U.S. launch planned for 1H 2027 with robust supply and payer strategy - TradingView
Achieve Life Sciences reports fourth-quarter results in line with expectations - MSN
ACHV: NDA review progresses for cytisinicline, with U.S. launch targeted for 1H 2027 amid strong clinical data - TradingView
Earnings call transcript: Achieve Life Sciences Q4 2025 reports stable EPS, stock dips - Investing.com
Achieve (ACHV) Advances Cytisinicline for Smoking Cessation Solu - GuruFocus
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected - AlphaStreet
Achieve Life Sciences meets fourth quarter estimates By Investing.com - Investing.com Australia
Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Achieve Life Sciences meets fourth quarter estimates - Investing.com
ACHIEVE LIFE SCIENCES ($ACHV) Releases Q4 2025 Earnings - Quiver Quantitative
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - The Manila Times
Achieve Life Sciences 2025 10-K: Net loss $54.6M, EPS $(1.25) - TradingView
Earnings Scheduled For March 24, 2026 - Benzinga
Cytisinicline outlook at Achieve Life Sciences (NASDAQ: ACHV) amid FDA review and cash risk - Stock Titan
Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision - Stock Titan
Achieve taps U.S. manufacturer for quit-smoking pill ahead of FDA date - Stock Titan
Achieve Life Sciences (ACHV) Q4 Earnings Preview: What to Expect - GuruFocus
Achieve Life Sciences Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 - The Manila Times
Nicotine-dependence drug developer schedules March 24 update on 2025 results - Stock Titan
Activity Recap: How does Achieve Life Sciences Inc score in quality rankingsPrice Action & AI Driven Stock Reports - baoquankhu1.vn
Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average – Time to Sell? - Defense World
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
ACHV PE Ratio & Valuation, Is ACHV Overvalued - Intellectia AI
Achieve Life Sciences, Inc. advances novel smoking cessation treatment at SRNT2026 - Traders Union
How Achieve Life Sciences Inc. stock reacts to global recession fearsQuarterly Market Review & AI Enhanced Trading Signals - Naître et grandir
Aug Breakouts: Is Achieve Life Sciences Inc stock influenced by commodity pricesWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Achieve Life Sciences outlines Late-breaking survey results on ORCA-OL unveiled - Traders Union
Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Achieve Life Sciences presents cytisinicline quit-smoking data - Investing.com
Achieve Life Sciences presents cytisinicline quit-smoking data By Investing.com - Investing.com UK
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study - marketscreener.com
New study: smokers who failed other quit drugs stop with cytisinicline - Stock Titan
ACHV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):